Status:
COMPLETED
A Study of Duloxetine in the Treatment of Fibromyalgia
Lead Sponsor:
Eli Lilly and Company
Collaborating Sponsors:
Boehringer Ingelheim
Conditions:
Fibromyalgia
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This study is designed to evaluate duloxetine for the treatment of fibromyalgia syndrome patients.
Eligibility Criteria
Inclusion
- Meet criteria for primary fibromyalgia syndrome as defined by the American College of Rheumatologists
Exclusion
- Treatment with a monoamine oxidase inhibitor within 14 days prior to Visit 2 or the potential need to take within 5 days after discontinuation from the study.
- Any patients judged by their physicians to be at serious suicidal risk.
- Have uncontrolled narrow-angle glaucoma
Key Trial Info
Start Date :
July 1 2005
Trial Type :
INTERVENTIONAL
End Date :
March 1 2007
Estimated Enrollment :
320 Patients enrolled
Trial Details
Trial ID
NCT00125892
Start Date
July 1 2005
End Date
March 1 2007
Last Update
May 17 2007
Active Locations (27)
Enter a location and click search to find clinical trials sorted by distance.
1
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday - Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician
Buenos Aires, Argentina
2
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday - Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician
Capital Federal, Argentina
3
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday - Friday from 9:00 AM to 5:00PM Eastern Time (UTC/GMT - 5 hours , EST) or speak with your personal physician
Cotton Tree, Queensland, Australia, 4558
4
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday - Friday from 9:00 AM to 5:00PM Eastern Time (UTC/GMT - 5 hours , EST) or speak with your personal physician
Malvern, Victoria, Australia, 3144